Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Predictors of Recurrent Stroke in the PROGRESS Study

This study has been completed.
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI) Identifier:
First received: November 14, 2002
Last updated: February 17, 2016
Last verified: October 2005
To investigate mechanisms of recurrent stroke.

Cardiovascular Diseases
Cerebrovascular Accident
Cerebrovascular Disorders

Study Type: Observational
Study Design: Time Perspective: Retrospective

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: September 2002
Study Completion Date: August 2004
  Show Detailed Description


Ages Eligible for Study:   up to 100 Years   (Child, Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
No eligibility criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00049894

Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
OverallOfficial: Duncan Campbell St. Vincent's Institute of Medical Research
  More Information

Publications: Identifier: NCT00049894     History of Changes
Other Study ID Numbers: 1201  R01HL071685 
Study First Received: November 14, 2002
Last Updated: February 17, 2016
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cardiovascular Diseases
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases processed this record on October 21, 2016